Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.338\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CN(C)c1nc(Nc2ccccc2)nc(N(C)C)n1
b COC1=C/C(=C/c2c(N)n3c(-c4ccccc4)csc3nc2=O)C=CC1=O
c O=C(/C=C\Nc1ccc2c(c1)OCO2)c1ccc2c(c1)OCO2
d COc1ccc(C2CC(c3ccccc3Cl)Nc3ncnn32)cc1OC
Answer: d. COc1ccc(C2CC(c3ccccc3Cl)Nc3ncnn32)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C2CC(c3ccccc3Cl)Nc3ncnn32)cc1OC
COc1ccc(C2CC(c3ccccc3Cl)Nc3ncnn32)cc1OC
5-(2-chlorophenyl)-7-(3,4-dimethoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidine